Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
EV/Core EBITDA

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 9.319.987.267.948.95

What is the latest EV/Core EBITDA ratio of AUROBINDO PHARMA ?

The latest EV/Core EBITDA ratio of AUROBINDO PHARMA is 9.31 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar20259.31
Mar20249.98
Mar20237.26
Mar20227.94
Mar20218.95

How is EV/Core EBITDA of AUROBINDO PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 9.31
-6.71
Mar2024 9.98
37.47
Mar2023 7.26
-8.56
Mar2022 7.94
-11.28
Mar2021 8.95 -

Other Financial Ratios of AUROBINDO PHARMA


Compare EV/Core EBITDA ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹66,132.8 Cr 4% 5.1% -23.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,452.0 Cr -0.3% 6% -10.5% Stock Analytics
DIVIS LABORATORIES ₹179,089.0 Cr 3.9% 18.6% 14.5% Stock Analytics
CIPLA ₹121,299.0 Cr -5.2% NA 2.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,456.0 Cr -1% -1.2% 8.7% Stock Analytics
DR REDDYS LABORATORIES ₹99,965.9 Cr -6.8% -2.1% -8.4% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

4%

5.1%

-23.1%

SENSEX

-0.3%

4.5%

5.7%


You may also like the below Video Courses